Massimo Gadina

1991–2025 年に発表

92
論文数
26,164
被引用数
69
h 指数
89
i10 指数

被引用数

Massimo Gadina の年別被引用数1964 年: 被引用 2 件1992 年: 被引用 3 件1993 年: 被引用 4 件1994 年: 被引用 3 件1995 年: 被引用 4 件1996 年: 被引用 6 件1997 年: 被引用 7 件1998 年: 被引用 10 件1999 年: 被引用 19 件2000 年: 被引用 25 件2001 年: 被引用 50 件2002 年: 被引用 103 件2003 年: 被引用 177 件2004 年: 被引用 184 件2005 年: 被引用 119 件2006 年: 被引用 126 件2007 年: 被引用 115 件2008 年: 被引用 107 件2009 年: 被引用 86 件2010 年: 被引用 92 件2011 年: 被引用 139 件2012 年: 被引用 133 件2013 年: 被引用 120 件2014 年: 被引用 109 件2015 年: 被引用 136 件2016 年: 被引用 200 件2017 年: 被引用 271 件2018 年: 被引用 273 件2019 年: 被引用 944 件2020 年: 被引用 1,195 件2021 年: 被引用 1,382 件2022 年: 被引用 1,188 件2023 年: 被引用 1,007 件2024 年: 被引用 1,445 件2025 年: 被引用 633 件2026 年: 被引用 20 件1965〜1991 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,192 件、この内訳の 24.8%中国: 引用元論文 1,663 件、この内訳の 12.9%イギリス: 引用元論文 783 件、この内訳の 6.1%ドイツ: 引用元論文 715 件、この内訳の 5.6%フランス: 引用元論文 611 件、この内訳の 4.7%イタリア: 引用元論文 588 件、この内訳の 4.6%日本: 引用元論文 555 件、この内訳の 4.3%カナダ: 引用元論文 367 件、この内訳の 2.9%オーストラリア: 引用元論文 332 件、この内訳の 2.6%スペイン: 引用元論文 297 件、この内訳の 2.3%オランダ: 引用元論文 290 件、この内訳の 2.3%スイス: 引用元論文 263 件、この内訳の 2%
0%24.8%その他 24.9%

分野

  • Medicine47%
  • Immunology and Microbiology25.7%
  • Biochemistry, Genetics and Molecular Biology22.3%
  • Neuroscience2%
  • Pharmacology, Toxicology and Pharmaceutics0.6%
  • Agricultural and Biological Sciences0.6%
  • その他1.8%

トピック

  • Cytokine Signaling Pathways and Interactions5.3%
  • interferon and immune responses4.5%
  • Inflammasome and immune disorders4.4%
  • Immune Cell Function and Interaction4.1%
  • T-cell and B-cell Immunology2.7%
  • Immune Response and Inflammation2.3%
  • その他76.7%

共著者

全論文

検索で開く
  1. The JAK-STAT pathway at 30: Much learned, much more to do

    著者: , , , , , , , , , - Cell 2022 被引用: 723

  2. JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects

    著者: , , , , - Drugs 2017 被引用: 1,192

  3. The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention

    著者: , , , , , - Annual Review of Medicine 2015 被引用: 1,577

  4. Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Natalie Deuitch, Dorota Rowczenio, Emily Rominger, Kristina V Wells, Chyi‐Chia Richard Lee, Weixin Wang, Megan Trick, James C. Mullikin, Gustaf Wigerblad, Stephen R. Brooks, Stefania Dell’Orso, Zuoming Deng, Jae Jin Chae, Alina Dulau‐Florea, May Christine V. Malicdan, Danica Novacic, Robert A. Colbert, Mariana J. Kaplan, Massimo Gadina, Sinisa Savic, Helen J. Lachmann, Mones Abu‐Asab, Benjamin D. Solomon, Kyle Retterer, William A. Gahl, Shawn M. Burgess, Ivona Aksentijevich, Neal S. Young, Katherine R. Calvo, Achim Werner, Daniel L. Kastner, Peter C. Grayson - New England Journal of Medicine 2020 被引用: 1,154

  5. JAK inhibition as a therapeutic strategy for immune and inflammatory diseases

    著者: , , , , , - Nature Reviews Drug Discovery 2017 被引用: 1,209

  6. Activated STING in a Vascular and Pulmonary Syndrome

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrei Barysenka, Fabio Candotti, Steven M. Holland, Jason D. Hughes, Huseyin Mehmet, Andrew C. Issekutz, M Raffeld, Joshua McElwee, JÉRǑMe Fontana, Caterina P. Minniti, Susan Moir, Daniel L. Kastner, Massimo Gadina, A.C. Steven, Paul T. Wingfield, Stephen R. Brooks, Sergio D. Rosenzweig, Thomas A. Fleisher, Zuoming Deng, Manfred Boehm, Amy S. Paller, Raphaela Goldbach‐Mansky - New England Journal of Medicine 2014 被引用: 1,387

  7. Type 2 immunity in the skin and lungs

    著者: , , , , , , , , , , - Allergy 2020 被引用: 552

  8. Erratum to: JAK–STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects

    著者: , , , , - Drugs 2017 被引用: 594

  9. Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cathrine Hall, Hongying Wang, Jae Jin Chae, Natalia I. Dmitrieva, Mark McKenzie, Amanda Light, Beverly Barham, Anne Jones, Tina Romeo, Qing Zhou, Ivona Aksentijevich, James C. Mullikin, Andrew J. Gross, Anthony K. Shum, Edwin D. Hawkins, Seth L. Masters, Michael J. Lenardo, Manfred Boehm, Sergio D. Rosenzweig, Manolis Pasparakis, Anne K. Voss, Massimo Gadina, Daniel L. Kastner, John Silke - Nature 2019 被引用: 333

  10. Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases

    著者: , , , - Nature Reviews Rheumatology 2015 被引用: 643

  11. JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Edward W. Cowen, John J. DiGiovanna, Massimo Gadina, Andrew Lipton, Colleen Hadigan, Steven M. Holland, Joseph R. Fontana, Ahmad S. Alawad, Rebecca J. Brown, Kristina I. Rother, Theo Heller, Kristina M. Brooks, Parag Kumar, Stephen R. Brooks, Meryl Waldman, Harsharan K. Singh, Volker Nickeleit, Maria Silk, Apurva Prakash, Jonathan Janes, Seza Özen, Paul Wakim, Paul Brogan, William L. Macias, Raphaela Goldbach‐Mansky - Journal of Clinical Investigation 2018 被引用: 521

  12. Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephen R. Brooks, Meggan Mackay, Peter K. Gregersen, Nehal N. Mehta, Alan T. Remaley, Betty Diamond, John J. O’Shea, Massimo Gadina, Mariana J. Kaplan - Nature Communications 2021 被引用: 197

  13. Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story

    著者: , , , , , , , , , - Annals of the Rheumatic Diseases 2023 被引用: 143

  14. Erratum: JAK inhibition as a therapeutic strategy for immune and inflammatory diseases

    著者: , , , , , - Nature Reviews Drug Discovery 2017 被引用: 382

  15. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ezgi Deniz Batu, Ahmet Gül, Richard M. Siegel, Manfred Boehm, Joshua D. Milner, Seza Özen, Massimo Gadina, JaeJin Chae, Ronald M. Laxer, Daniel L. Kastner, Ivona Aksentijevich - Nature Genetics 2015 被引用: 633

  16. Protein kinases: drug targets for immunological disorders

    著者: , , , , , - Nature reviews. Immunology 2023 被引用: 107

  17. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sinisa Savic, Daniel L. Kastner, Amanda K. Ombrello, David B. Beck, Peter C. Grayson - Arthritis & Rheumatology 2021 被引用: 238

  18. Development of a Validated Interferon Score Using NanoString Technology

    著者: , , , , , , , , , - Journal of Interferon & Cytokine Research 2018 被引用: 184

  19. Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)

    著者: , , , , , , , , , , , , , , , , , , , - The Journal of Immunology 2011 被引用: 644

  20. JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition

    著者: , , , , , - Journal of Allergy and Clinical Immunology 2021 被引用: 115

  21. Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heidi H. Kong, Sophie Hambleton, Fabio Candotti, Martha Quezado, Katherine R. Calvo, Hawwa Alao, Beverly Barham, Anne Jones, James F. Meschia, Bradford B. Worrall, Scott E. Kasner, Stephen S. Rich, Raphaela Goldbach‐Mansky, Mario Abinun, Elizabeth Chalom, Alisa Gotte, Marilynn Punaro, Virginia Pascual, James Verbsky, Troy R. Torgerson, Nora G. Singer, Timothy R. Gershon, Seza Özen, Ömer Karadağ, Thomas A. Fleisher, Elaine F. Remmers, Shawn M. Burgess, Susan Moir, Massimo Gadina, Raman Sood, Michael S. Hershfield, Manfred Boehm, Daniel L. Kastner, Ivona Aksentijevich - New England Journal of Medicine 2014 被引用: 893

  22. Cytokine Signaling in 2002

    著者: , , - Cell 2002 被引用: 1,126

  23. Germline Mutations in the Extracellular Domains of the 55 kDa TNF Receptor, TNFR1, Define a Family of Dominantly Inherited Autoinflammatory Syndromes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , G. A. Hitman, John J. O’Shea, Daniel L. Kastner - Cell 1999 被引用: 1,421

  24. An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Massimo Gadina, Barbara Yang, Benjamin D. Korman, Peter K. Gregersen, P. Martin van Hagen, A. Elisabeth Hak, Marjan Huizing, Proton Rahman, Daniel C. Douek, Elaine F. Remmers, Daniel L. Kastner, Raphaela Goldbach‐Mansky - New England Journal of Medicine 2009 被引用: 992